XPO1 inhibition sensitises CLL cells to NK cell mediated cytotoxicity and overcomes HLA-E expression. Fisher JG, Doyle ADP, Graham LV, Sonar S, et al. Leukemia 2023;37:2036-2049.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Fisher JG, Doyle ADP, Graham LV, Sonar S, et al. XPO1 inhibition sensitises CLL cells to NK cell mediated cytotoxicity and overcomes HLA-E expression. Leukemia 2023;37:2036-2049.
PMID: 37528310